Back to News
Market Impact: 0.35
Santé Canada autorise deux vaccins à ARNm de Moderna : un vaccin contre la grippe et un vaccin combiné contre la grippe et la COVID-19
Source: Newswire
Healthcare & BiotechProduct Launches
Canada became the first country to authorize Moderna’s mRNA seasonal influenza vaccine, mFLUSIVA, and its combined influenza/COVID-19 vaccine, mCOFLU. The approvals expand the vaccines’ regulatory availability; the article provides no sales outlook or market reaction.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
moderately positive
Sentiment Score
0.45
Ticker Sentiment
MRNA0.80
More News
- e.l.f. CEO: All of Our Brands Are Growing
- We're raising our price target on Cardinal Health after another stellar quarter of profits
- Halozyme falls 6% as raised guidance fails to impress investors
- OpenAI debuts new cybersecurity-focused AI model amid growing alarm about AI-driven cyber attacks
- Airbnb is working on an AI travel agent
- Dentsply earnings missed by $0.02, revenue fell short of estimates